{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:15:36Z","timestamp":1790198136631,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005633","name":"Finnish Foundation for Cardiovascular Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Fund"},{"DOI":"10.13039\/501100011797","name":"Turku University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Finnish Foundation for Cardiovascular Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Finnish Foundation for Cardiovascular Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"Astra Zeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.hrthm.2020.01.028","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T11:48:37Z","timestamp":1580989717000},"page":"915-921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Percutaneous left atrial appendage closure in patients with prior intracranial bleeding and thromboembolism"],"prefix":"10.1016","volume":"17","author":[{"given":"Jussi-Pekka","family":"Pouru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuli","family":"Jaakkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuija","family":"Vasankari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Biancari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Saraste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.E. Juhani","family":"Airaksinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2020.01.028_bib1","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.01.028_bib2","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.01.028_bib3","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2020.01.028_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1474-4422(12)70042-X","article-title":"Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF","volume":"11","author":"Hankey","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hrthm.2020.01.028_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145579","article-title":"Risk of ischemic stroke after intracranial hemorrhage in patients with atrial fibrillation","volume":"10","author":"Lerario","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2020.01.028_bib6","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1378\/chest.14-2099","article-title":"Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study","volume":"147","author":"Br\u00f8nnum Nielsen","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.hrthm.2020.01.028_bib7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.hrthm.2020.01.028_bib8","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.028_bib9","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","article-title":"Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)","volume":"61","author":"Reddy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.028_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006841","article-title":"Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the Watchman left atrial appendage closure technology","volume":"12","author":"Boersma","year":"2019","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.01.028_bib11","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.4244\/EIJ-D-18-00344","article-title":"Left atrial appendage occlusion with the Amplatzer Amulet device: one-year follow-up from the prospective global Amulet observational registry","volume":"14","author":"Landmesser","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.hrthm.2020.01.028_bib12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.11.126","article-title":"Left atrial appendage closure in patients with atrial fibrillation and previous intracerebral hemorrhage","volume":"26","author":"Renou","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.hrthm.2020.01.028_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1212\/WNL.0000000000000022","article-title":"Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage","volume":"82","author":"Horstmann","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.hrthm.2020.01.028_bib14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.hrthm.2018.11.022","article-title":"Left atrial appendage closure device implantation in patients with prior intracranial hemorrhage","volume":"16","author":"Hutt","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2020.01.028_bib15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijcard.2017.02.042","article-title":"Patients with intracranial bleeding and atrial fibrillation treated with left atrial appendage occlusion: results from the Amplatzer Cardiac Plug registry","volume":"236","author":"Tzikas","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.028_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4244\/EIJ-D-17-00201","article-title":"Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up study","volume":"13","author":"Nielsen-Kudsk","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.hrthm.2020.01.028_bib17","first-page":"349","article-title":"Left atrial appendage closure for atrial fibrillation is safe and effective after intracranial or intraocular hemorrhage","volume":"32","author":"Fahmy","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.028_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.recesp.2016.08.021","article-title":"Safety and effectiveness of percutaneous closure of left atrial appendage in patients with intracranial hemorrhage","volume":"70","author":"Cruz-Gonz\u00e1lez","year":"2017","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.028_bib19","first-page":"30242","article-title":"Left atrial appendage closure in patients with intracranial haemorrhage and atrial fibrillation","volume":"17","author":"Fayos-Vidal","year":"2017","journal-title":"Neurologia"},{"key":"10.1016\/j.hrthm.2020.01.028_bib20","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2013.04.089","article-title":"Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study","volume":"62","author":"Airaksinen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.028_bib21","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1016\/j.ijcard.2013.06.022","article-title":"Safety of pacemaker and implantable cardioverter\u2013defibrillator implantation during uninterrupted warfarin treatment\u2014the FinPAC study","volume":"168","author":"Airaksinen","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.028_bib22","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.amjcard.2019.08.050","article-title":"Effectiveness of only aspirin or clopidogrel following percutaneous left atrial appendage closure","volume":"124","author":"Pouru","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.028_bib23","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/j.thromres.2012.05.013","article-title":"Percutaneous left atrial appendage closure with minimal antithrombotic treatment in patients at very high risk of bleeding events","volume":"130","author":"Lund","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.hrthm.2020.01.028_bib24","first-page":"4","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies","volume":"19","author":"Tzikas","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2020.01.028_bib25","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.hrthm.2020.01.028_bib26","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2020.01.028_bib27","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2020.01.028_bib28","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"46","author":"Hemphill","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2020.01.028_bib29","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1212\/WNL.0000000000003886","article-title":"Outcome of intracerebral hemorrhage associated with different oral anticoagulants","volume":"88","author":"Wilson","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.hrthm.2020.01.028_bib30","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1161\/STROKEAHA.108.520668","article-title":"Hematoma growth in oral anticoagulant related intracerebral hemorrhage","volume":"39","author":"Cucchiara","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2020.01.028_bib31","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/STROKEAHA.115.009087","article-title":"Antithrombotic treatment following intracerebral hemorrhage in patients with and without atrial fibrillation","volume":"46","author":"Pennlert","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2020.01.028_bib32","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(12)60986-6","article-title":"Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial","volume":"380","author":"Lopes","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2020.01.028_bib33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/ene.13280","article-title":"Stroke recurrence in patients with atrial fibrillation: concomitant carotid artery stenosis doubles the risk","volume":"24","author":"Lehtola","year":"2017","journal-title":"Eur J Neurol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120300837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120300837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:50:40Z","timestamp":1761547840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527120300837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1547527120300837"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.01.028","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Percutaneous left atrial appendage closure in patients with prior intracranial bleeding and thromboembolism","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}